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ABSTRACT
The protozoan parasite Toxoplasma gondii differen-
tially expresses two distinct enolase isoenzymes
known as ENO1 and ENO2, respectively. To under-
stand differential gene expression during tachyzoite
to bradyzoite conversion, we have characterized the
two T.gondii enolase promoters. No homology could
be found between these sequences and no TATA or
CCAAT boxes were evident. The differential activa-
tion of the ENO1 and ENO2 promoters during
tachyzoite to bradyzoite differentiation was investig-
ated by deletion analysis of 50-flanking regions fused
to the chloramphenicol acetyltransferase reporter
followed by transient transfection. Our data indicate
that in proliferating tachyzoites, the repression of
ENO1 involves a negative distal regulatory region
(nucleotides  1245 to  625) in the promoter whereas
a proximal regulatory region in the ENO2 promoter
directs expression at a low level. In contrast, the pro-
moteractivityofENO1ishighlyinducedfollowingthe
conversion of tachyzoites into resting bradyzoites.
The ENO2 promoter analysis in bradyzoites showed
that there are two upstream repression sites (nucleo-
tides 1929to 1067and 456to 222).Furthermore,
electrophoresis mobility shift assays demonstrated
the presence of DNA-binding proteins in tachyzoite
and bradyzoite nuclear lysates that bound to stress
response elements (STRE), heat shock-like elements
(HSE) and other cis-regulatory elements in the
upstream regulatory regions of ENO1 and ENO2.
Mutation of the consensus AGGGG sequence,
completely abolished protein binding to an oligonuc-
leotide containing this element. This study defines
the first characterization of cis-regulatory elements
and putative transcription factors involved in gene
regulation of the important pathogen T.gondii.
INTRODUCTION
Toxoplasma gondii is an obligate intracellular protozoan para-
site that is capable of infecting most nucleated mammalian
cells. It is an important opportunistic pathogen that is becom-
ing a major threat to immunocompromised hosts, such as
patients with the acquired human immunodeﬁciency virus
(AIDS) infection (1,2). The parasite can also cause severe
congenital disease to the growing foetus during pregnancy
(3). Cats and felines in general are the ﬁnal hosts for the
parasite, but man and a wide range of other animals may
serve asintermediate hosts. The parasite istransmitted through
consumption of raw or undercooked tissue cyst infected meat
orby oocyst ingestion produced by the ﬁnalhosts. The parasite
has a complex life cycle involving asexual and sexual stages
in the infected hosts. This includes a rapidly growing stage
known as the tachyzoite and a slowly dividing stage called
the bradyzoite. The bradyzoite is also a cyst forming stage.
Encysted bradyzoites escape the immune system and there-
fore remain in the host during their lifetime. If allowed to do
so, in immunocompromised hosts and AIDS patients, they will
convert back to the tachyzoite form and reactivate toxoplas-
mosis. This reactivation deﬁnes the cause of fatal encephalitis
in immunocompromised Toxoplasma infected patients (2).
The factors that trigger Toxoplasma differentiation are not
very well known, and a better understanding of these factors
will help in the control and treatment of toxoplasmosis.
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transfection in T.gondii (4,5) has allowed the generation of
mutants that has lead some insights into the molecular
processes of parasite differentiation and pathogenesis (6,7).
In vitro culture studies have also been valuable in under-
standing the possible factors involved in Toxoplasma
differentiation. In vitro studies of tachyzoite to bradyzoite
conversion suggested that this process was linked to a num-
ber of stress factors. These included an increase in culture
temperature or a change in pH of the culture medium (8).
Similarly, agents inducing nitric oxide production (9) or
inhibitors of mitochondrial function (10) were also demon-
strated to induce bradyzoite formation. Several morpho-
logical and metabolic changes accompany Toxoplasma
differentiation. This is evident from stage-speciﬁc expression
of genes that are probably involved in the differentiation
process. Some cell surface parasite molecules as well as
key glycolytic isoenzymes were found to be stage speciﬁc
(11–14).
Enolase (2 phospho-D-glycerate hydrolase, EC 4.2.1.11) is
a glycolytic metal-activated metalloenzyme belonging to the
enolase superfamily (15). The enzyme catalyses the Mg
2+-
dependent reversible dehydration of 2-phospho-D-glycerate
to phosphoenolpyruvate during both glycolysis and gluconeo-
genesis. The enzyme from a large variety of organisms is
conserved and biologically active as a dimer with subunits
of  45–48 kDa. The protein appears to serve other functions
in some organisms. It is a major lens protein in some verteb-
rates (16). In yeast, it was found to be identical to the heat
shock protein HSP 48 and is involved in thermal tolerance and
growth control in this organism (17). In T.gondii, enolase was
found to be differentially expressed (12,13). The parasite
expresses two plant-like enolases (ENO1 and ENO2) with
distinct enzymatic and antigenic properties (13). The two eno-
lases were found to be encoded by single copy genes while
the deduced amino acid sequences showed 73.65% identity
(13). Semi-quantitative reverse transcriptase PCR analysis
demonstrated that ENO1 mRNA was only detected in the
bradyzoites isolated from chronically infected mice while
ENO2 mRNA was exclusively found in the tachyzoites
(12,13). The absence of ENO1 mRNA in the tachyzoite
stage suggested repression of ENO1 transcription during
bradyzoite to tachyzoite conversion.
The transcription of protein coding genes by RNA
polymerase II in eukaryotes is directed by speciﬁc sequence
elements that bind transcription factors in the promoters of
these genes (18). Other upstream or downstream regulatory
sequences may regulate gene transcription as well.InT.gondii,
the gene-regulatory processes governing development are
poorly understood, and of particular interest are the molecular
mechanisms underlying the tachyzoite to bradyzoite stage
conversion. It should be mentioned that, despite the isolation
and characterization of numerous genes, no functional TATA
and CCAAT boxes have yet been described in T.gondii. In our
efforts to understand the stage-speciﬁc transcription of enolase
isoenzymes, we have cloned and sequenced the promoters of
the two T.gondii enolase genes. Transient transfection of pro-
moter constructs allowed the identiﬁcation of regions neces-
sary for the transcription of both genes. Sequence-speciﬁc
promoter regions that bind to putative transcription factors
were mapped precisely.
MATERIALS AND METHODS
Cultivation of parasites
T.gondii strain 76K tachyzoites were propagated in vitro
in human foreskin ﬁbroblasts (HFF) using DMEM (Bio
Whittaker)supplementedwith10%fetalcalfserum(Dutscher),
2 mM glutamine and 0.05% gentamycin. Bradyzoite differen-
tiation was induced in vitro by culturing tachyzoite infected
cells in absence of CO2 (19) and encysted bradyzoites freed by
pepsin digestion (0.05 mg/ml pepsin in 170 mM NaCl, 60 mM
HCl). Tachyzoites were allowed to grow until they lysed HFF
cells spontaneously and were harvested by ﬁltration through a
glass wool column and through a 3 mm pore ﬁlter.
Cloning of ENO1 and ENO2 flanking sequences
A PCR DNA fragment was generated from the ENO2 open
reading frame (ORF) using the sense 50-CTACCGTTACTCA-
ACTTCCAAC-30 and antisense 50-CCAATATTATCAACG-
AAACTGC-30 oligonucleotide primers. The 1.6 kb PCR
product was labelled using a non-radioactive labelling kit
(Boehringer) according to the manufacturer’s instructions.
The probe was used to screen a T.gondii strain 76K genomic
library made in the bacteriophage lambda DashII vector
(Stratagene). Brieﬂy, E.coli XL1 blue P2 cells (Stratagene)
were infected with the recombinant phages containing insert
size of 10–20 kb and about 500000 phage plaques were lifted
on to hybond N+ membranes (Amersham). Plaque lifts were
treated as previously described (20), and then hybridized with
the digoxigenin-11-dUTP labelled ENO2 probe.Hybridization
was done overnight at 42 C in hybridization buffer (2% block-
ing reagent, 5· SSC, 0.1% N-lauroyl-sarcosine, 0.02% SDS
and 50% formamide). Filters were washed at room tem-
perature with 2· SSC, 0.1% SDS and at higher stringency
(0.1· SSC, 0.1% SDS at 68 C). Filters were then washed
for 5 min in maleic acid washing buffer (0.1 M maleic acid
pH 7.5, 0.15 M NaCl, 0.3% Tween-20) and incubated for
30 min in blocking buffer (1% blocking reagent in 0.1 M
maleic acid pH 7.5, 0.15 M NaCl). An anti-digoxigenin alkal-
ine phosphatase-conjugated antibody was diluted (1:10000) in
blocking buffer and incubated with the ﬁlters for 30 min.
Filters were washed twice in washing buffer. The hybridizing
plaques were detected by chemiluminescence using CDP-Star
substrate (Boehringer) diluted in detection buffer (0.1 M Tris–
HCl pH 9.5, 0.1 M NaCl). After the primary screen, positive
plaques were rescreened with the same probe and the puriﬁed
plaques used to make phage DNA (20). Phage DNA was
digested with the appropriate restriction enzymes and sub-
cloned into pBluescript plasmid vector (Stratagene). Plasmid
DNA was sequenced by the dideoxy chain termination
method using ALF express Autoread or Thermo-sequenase
dye terminator sequencing kits (Amersham). Sequence reac-
tions were run on an ALF express sequencer (Amersham), and
data analysis and sequence alignments were performed using
software programs available from the Swiss Institute of Bio-
informatics ExPASy Molecular Biology Server or from the
resources centre INFOBIOGEN.
Construction of ENO1 and ENO2 reporter plasmids
Plasmid constructs for transfection were made from PCR-
ampliﬁed DNA fragments using pairs of forward and reverse
primers. For ENO1 constructs, the following forward primers
Nucleic Acids Research, 2005, Vol. 33, No. 5 1723E1F: AGCCCCCATGGCACCTCCAGTCA, E1F1: TGGA-
CAGTCTGGCATGTGAGTTGC, E1F2: TATCACATGT-
GAGATGTGAC, E1F3: GCAACAAGCTGCTGTGTGC-
CACGC, E1F4: CTGATAATCAAGCTTTGGCTGG were
combined with ENO1rev: CATCGTGACAGGCGCGTAG-
ATGAG. For ENO2 constructs, each forward primer E2F:
TATCGTCGCATCGGAAATGCG, E2F1: TTCTGATTTA-
CCGATTGTGTAAGG, E2F2: CAGCCTGTGTTCTGC-
TGGATGTGA, E2F3: CGCGGATCCGCACACGTACAA-
GCG, E2F4: GCGGAACGGCGGTCGCATGTCTCAT,
E2F5:CGTCCCATTACGTTTTCCTTTTTGCwascombined
with ENO2rev: CATTTTGTTGGAAGTTGAGTAACGGT.
The sense primer contained a ClaI restriction site and the
antisense primer an NsiI site. The PCR was done using
20 ng of DNA template and 50 pmol of each primer. The
reactions were cycled for 35 times by heating at 95 C for
1 min, annealing at 57 C for 1 min, elongation at 72 C for
2 min and a ﬁnal elongation step for 10 min at the same tem-
perature. Buffers and Taq DNA polymerase used for PCR
were from Promega. PCR-ampliﬁed DNA was digested with
ClaI and NsiI restriction enzymes, gel puriﬁed using a gene
clean spin kit (Qbiogene) and cloned into the reporter vector.
All constructs were derived from the basic pTUB5CAT (5) by
removing the TUB5 promoter using ClaI and NsiI restriction
enzymesand replacingit with the enolase promoterconstructs.
Thus, these constructs contained the 30-untranslated region
(30-UTR) of the major surface antigen 1 gene (SAG1) of the
original pTUB5/CAT (5). To generate constructs with ENO1
and ENO2 30-ﬂanking sequences, the 30 SAG1 sequence was
then removed from pTUB5CAT or from ENO1 or ENO2 pro-
moter constructs by digesting the plasmids with PacI and NotI
restriction enzymes. Oligonucleotide primers containing PacI
and NotI restriction enzyme sites were used to amplify
30-UTRs of the ENO1 and ENO2 genes. The ampliﬁed DNA
was cut with the same restriction enzymes and cloned into the
vectors.
Transfection and CAT assays
T.gondii (76K strain) tachyzoites were grown and puriﬁed as
described above. Cells (1.0 · 10
7) were washed once in PBS
and resuspended in 800 ml of cytomix buffer (120 mM KCl,
0.15 mM CaCl2,1 0m MK 2HPO4/KH2PO4 pH 7.6, 25 mM
HEPES pH 7.6, 2 mM EGTA, 5 mM MgCl2) containing 2 mM
ATP pH 7.6, 5 mM glutathione and 50 mg of plasmid construct
and 20 mg of control plasmid GRA1/LacZ for b-galactosidase
activity. Electroporation was done in a 4mm gap cuvette using
a BTX electro cell manipulator 600 (BTX, San Diego) set at a
voltage of 2.5 kV cm 1,2 5mF capacitance and 48 V serial
resistance (5). Electroporated cells were immediately allowed
to infect HFF monolayer cells for about 6 h after which fresh
medium was added. Cells were grown for 48 h and then
harvested for CAT assays. For CAT assays, HFF-infected
monolayers were harvested, centrifuged at 800 g and the
cell pellet washed once in PBS pH 7.5. The cells were then
resuspended in 100 ml of 0.25 M Tris–HCl pH 7.8 and a lysate
prepared by four cycles of freezing in liquid nitrogen and
thawing at 37 C. The lysate was centrifuged at 14000 g
and the supernatant used immediately for CAT assays or
stored at  20 C until used. CAT and b-galactosidase assays
were performed as previously described (5,21).
RNA isolation
Total RNA was isolated from tachyzoites and from in vitro-
differentiated bradyzoites. RNA was isolated from the para-
sites by a hot phenol method. Brieﬂy, parasites were lysed in
200 ml lysis buffer (1% SDS, 50 mM NaC2H2O2 and 10 mM
EDTA). An equal volume of phenol (pH 5.2) was added and
the mixture vortexed and incubated at 65 C for 15 min. After
centrifugation at 14000 g for 10 min, the upper aqueous phase
was removed and the phenol phase extracted again with 100 ml
of lysis buffer as before. The aqueous phases were combined
and extracted twice with an equal volume of phenol/chloro-
form, once with an equal volume of chloroform alone and the
RNA precipitated with ethanol. The RNA was treated with
RNase-free DNase1 (1 U/mg RNA) re-extracted as above and
precipitated with ethanol. The RNA was used immediately for
primer extension analysis or stored in ethanol at  80 C.
Primer extension analysis
Oligonucleotide primers (10 pmol) were end-labeled at 37 C
with [g-
32P]ATP (Amersham) using 10 U of polynucleotide
kinase (New England Biolabs). The labelled oligonucleotides
were then passed through sephadex G-50 quick spin columns
(Roche) and precipitated together with 10 mg of total
RNA. The sequences of the antisense oligonucleotides were
50-CCAAAATCTCGCGTGCAACGATGTC-30 for ENO1 and
50-CGAGGATCTGACGAGCAGTGATGTC-30 for ENO2.
After precipitation and washing in 80% ethanol, the pellet
was dried and resuspended in RNase-free water containing
1· ﬁrst strand cDNA buffer (50 mM Tris–HCl, 6 mM
MgCl and 75 mM KCl). The primers were annealed to the
RNA by heating at 60 C for 1 h and cooling slowly at room
temperature. After this, 40 U of rRNasin (Promega), 150 mM
dNTPs and 100 U of Powerscript reverse transcriptase (Strata-
gene) were added and the reaction incubated at 42 C for 1.5 h.
The reaction (50 ml) was stopped by adding 1 ml of 0.5 M
EDTA (pH 8.0) and DNase-free RNase A was added to a ﬁnal
concentration of 5 mg/ml, and the reaction incubated at 37 C
for 30 min. Three volumes ofTE pH7.5 (10mM Tris–HCland
1 mM EDTA) containing 100 mM NaCl were added and the
reaction extracted with an equal volume of phenol/chloroform.
After centrifugation at 12000 g, the aqueous phase containing
the primer extension products was precipitated with 2.5
volumes of ethanol and the pellet washed, dried and
resuspended in 4 ml of TE. Then, 6 ml of formamide loading
buffer was added and the extension products boiled for 2 min
at 95 C, chilled immediately on ice and then loaded on a 6%
polyacrylamide gel. A sequence reaction with the same pri-
mer prepared with the Sequenase
TM Quick-Denature Plasmid
Sequencing Kit (United States Biochemicals) was run next to
the primer extension product to act as a marker.
Nuclear extracts
Nuclear extracts for band shift assays were obtained from
about 5 · 10
9 tachyzoites or 2 · 10
9 bradyzoites obtained
in vitro (19). The parasites were harvested as described above
and washed once in cold PBS and then resuspended in 4 ml of
ice-cold buffer A (10 mM HEPES pH 7.9, 1.5 mM MgCl2,
10 mM KCl, 0.5 mM DTT, 0.1 mM EDTA, 0.65% NP40 and
0.5 mM PMSF). The parasite lysate was incubated for 10 min
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supernatant was discarded and the nuclei pellet was lysed by
resuspendingin400mlofBufferB(20mMHEPESpH7.9,1.5
mM MgCl2, 420 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT,
25% glycerol and 0.2 mM PMSF). After incubation on ice
for 15 min, nuclear extracts were centrifuged at 14000 g for
10 min at 4 C. The supernatant was aliquoted in 30 ml volumes
and stored at  80 C. The protein concentration in the nuclear
lysate was determined by the Bradford method.
Electrophoresis mobility shift assays
Electrophoresis mobility shift assays (EMSA) were performed
using a band shift assay kit (Amersham) following the manu-
facturer’s instructions. Brieﬂy, DNA fragments (50–300 bp)
were generated by PCR using primers originally designed
for sequencing the promoters of ENO1 and ENO2 genes. The
smaller fragments,whose sizes rangedfrom  40 to50bp were
also generated by PCR and the products resolved on 1.5–2%
agarosegels.Inourexperience,fragmentsabove50bpcouldbe
puriﬁed using the geneclean spin kit (Qbiogene). However,
fragments smaller than this were puriﬁed by electrophoresis
in dialysis membranes. About 100 ng of the puriﬁed DNA was
dephosphorylated with 20 U of calf intestine alkaline phos-
phatase (Roche) in dephosphorylation buffer (50 mM Tris–
HCl and 0.1 mM EDTA). The enzyme was heat-inactivated
at 65 C for 10 min and an equal volume of TE (50 ml) added
to the reaction which was then extracted once with an equal
volume of phenol/chloroform. Another extraction was done
with an equal volume of chloroform and the DNA precipitated
with ethanol at  80 C for at least 30 min and then centrifuged
at 14000 g for 20 min. The DNA pellet was air-dried and then
end-labelledwith[g-
32P]ATP(Amersham)using10Uofpoly-
nucleotide kinase. To label oligonucleotides, single-stranded
oligonucleotides were annealed in buffer (10 mM Tris–HCl,
pH7.5and50mMNaCl)byheatingat95 Cfor5min,65 Cfor
15 min, 55 C for 15 min and 37 C for 30 min. The annealed
oligonucleotides (500 fmol) were labelled by a ﬁll-in-reaction
with [a-
32P]dATP (Amersham) using 5 U of Klenow DNA
polymerase I (New England Biolabs). Alternatively, they
were end-labelled with [g-
32P]ATP using 10 U of poly-
nucleotide kinase. The labelled DNA fragments or oligo-
nucleotides were puriﬁed by passage through a Sephadex
G-50 column. The probes were used immediately or stored
at  20 C and used within one week. For gel shift assays,
labelled DNA fragments (2–5 ng), or double-stranded oligo-
nucleotides (20 fmol) were incubated for 20 min at room tem-
peraturewith5mgofnuclearextractsinbindingbuffer(10mM
Tris–HClatpH7.5,50mMNaCland0.5mMDTT)containing
1 mg Poly(dI–dC):Poly(dI–dC) (Amersham), 0.01% NP40 and
10% glycerol. For competition experiments, 10- to 50-fold
excess of self or unrelated unlabelled DNA fragments or 50-
to 300-fold excess of unlabelled double-stranded oligonuc-
leotides were added to the binding reaction together with the
nuclear extracts before addition of the labelled probe. To the
bound and unbound DNA–protein complexes, loading dye
(25 mM Tris–HCl at pH 7.5, 0.02% bromophenol blue,
0.02% xylene and 4% glycerol) was added and the complexes
separated on 6% non-denaturing polyacrylamide gels in run-
ning buffer (7 mM Tris–HCl at pH 7.5, 3 mM NaC2H2O2 and
1 mM EDTA).
Nucleotide sequence accession number of ENO1 and
ENO2 genes
Sequence data have been submitted to the GenBank database
under accession no. AY155668.
RESULTS
Structure of the ENO1 and ENO2 upstream and
downstream regions
A T.gondii genomic library constructed in a lambda Dash II
vector was screened with the 1.6 kb ENO2 probe. A genomic
DNA fragment hybridizing to the probe was subcloned and
sequenced. The information derived from the sequence indic-
ated that both ENO1 and ENO2 genes were located in this
fragment.Thewholesequenceobtainedfromtheenolaselocus
was  9.3 kb and contained sequences from the ORFs of ENO1
and ENO2, putative promoter sequences of both genes and
 2 kb sequence downstream of the ENO1 gene (Figure 1A).
A comparison of the genomic sequence with the cDNA
sequences of ENO1 and ENO2 (12,13) showed that both
genes contained single introns located exactly at the same
position (Figure 1A). The sizes of the introns in both genes
were different but both started 40 bp downstream of their ATG
initiation codons. The intron in ENO1 genomic DNA was 493
bp while that of ENO2 was 650 bp. The consensus splicing
donor and acceptor sequences were conserved and similar to
those of other eukaryote genes with a GT at the 50 end and an
AG at the 30 end of the intron. The sequences of the introns
were completely different and had no homologous regions
in their entire sequences. The sequences of the two putative
promoters of T.gondii enolases were also completely different.
The A/TGAGACG repeats identiﬁed in other T.gondii pro-
moters and shown to be critical for the transcription of these
genes (22,23) were not evident. Similarly, TATA and CCAAT
boxes often found within 100 bases upstream of the transcrip-
tion start sites and common in many eukaryotic genes could
not be identiﬁed. The initiator element with the consensus
sequence TCAGTTT which was identiﬁed in the nucleoside
triphosphate hydrolase genes of T.gondii (24) was not found in
either promoter.
Determination of the transcription initiation sites of
the ENO1 and ENO2 genes
As an initial step in the characterization of the ENO1 and
ENO2 promoters, we mapped the transcription start sites of
the respective genes using primer extension. When mRNA
was isolated from tachyzoites, ENO2 gene was shown to con-
tain two transcription start sites located at  104 and  175
upstream of the ATG codon (Figure 1B) while no signal was
detected with the ENO1 probes (data not shown), conﬁrming
the transcriptional repression or the absence of ENO1 mes-
senger in the tachyzoites. The ENO1 transcription start sites
were only detected usingmRNA isolated from in vitro induced
bradyzoites. In this case, the bradyzoite ENO1 extension pro-
ducts revealed multiple initiation sites with two major sites at
 89and 92upstreamoftheATGcodon(Figure1C).Several
other minor initiation sites were also evident upstream and
downstream of the two major initiation sites of ENO1 at
 22,  110,  123,  190,  242 and  316 position relative to
Nucleic Acids Research, 2005, Vol. 33, No. 5 1725the ATG. The nucleotide positions of these transcription start
sites are also shown in Figure 1A. The presence of multiple
transcription start sites in the ENO1 gene was also conﬁrmed
by 50RACE. After nucleotide sequencing of the 50RACE pro-
ducts, the existence of several 50 DNA fragments with differ-
ent nucleotide lengths conﬁrms the primer extension data (data
not shown). We could not rule out the possibility that some of
the minor transcription initiation sites and 50RACE fragments
observed in ENO1 can be associated with the degradation of
the primary transcript. Nevertheless, our data remain in good
agreement with the presence of multiple transcription start
sites that are indeed frequently seen in higher eukaryotic pro-
moters lacking TATA and CCAAT boxes (25–27).
Functional mapping of the ENO2 and ENO1 promoters
To gain insight into the DNA elements involved in the
expression of the ENO1 and ENO2 genes, a series of reporter
plasmids containing various lengths of the ENO1 (from nuc-
leotides  1245 to  59) and ENO2 (from nucleotides  1929
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Figure 1. (A) Tandemly arrayed organization of the two stage-specific T.gondii enolase genes. Approximately 9.3 kb of the whole sequence of both enolase loci is
drawn to scale. Both ENO1 and ENO2 genes contained single dissimilar introns located 40 bp downstream of their ATG initiation. An intron of 493 bp is present in
ENO1 genomic DNA while ENO2 contains an intron of 650 bp. The transcription start sites of ENO1 and ENO2 are indicated by vertical arrows and the numbers
abovecorrespondtotheirnucleotidepositionsrelativetotheATGcodon.30E2indicatesthe242bpofthe30-UTRofENO2(uptothepolyadenylationsignal)plusthe
441 bp of the adjacent 50-flanking region of ENO1 (distal promoter). 30E1 corresponds to the 30-UTR of ENO1. Some restriction enzyme sites ApaI (A), EcoRI (R),
BamHI (B), HindIII (H), PstI (P) and NotI (N) are indicated. (B and C) Mapping of the transcription start sites of ENO2 and ENO1 by primer extension using RNA
fromtachyzoitesandbradyzoites,respectively.NotethatonemajortranscriptionstartsiteandaminoronewereobtainedforENO2(arrows)whereasENO1gavetwo
major,andatleastfiveminortranscriptionstart sites(arrows).ThelettersA,C, GandTindicatetheproductsofa sequencingreactionthatwasrunalongtheprimer
extension fragments for size determination.
1726 Nucleic Acids Research, 2005, Vol. 33, No. 5to  55) 50-ﬂanking regions upstream of the CAT gene were
transfected into the tachyzoites. Transient transfections of
these various deletion constructs gave rise to low CAT activ-
ities for both ENO1 and ENO2, suggesting that T.gondii eno-
lase genes exhibited weak promoter activity similar to that
found with the surface antigen gene 1 (SAG1) (23) and lactate
dehydrogenase (LDH) promoters (14). Serial deletion of the
ENO2 promoter leads to consistent and progressive decrease
of CAT activity, suggesting that the construct E2F4 (deletions
upto 222bpupstream oftheATGcodon) maycontainallthe
cis-regulatory elements necessary for the expression of ENO2
gene (Figure 2A). In contrast, when CAT-chimeric constructs
of the ENO1 promoter were transfected into the tachyzoites,
the region with the ﬁrst 620 bp downstream of the ENO2
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Figure 2. Identification of transcriptional regulatory elements in the ENO1 and ENO2genes by transient CATassays. Transfections of tachyzoites were performed
withENO2(A)andENO1(B)promoter–reporterconstructsthatareschematicallydepictedontheleftofthepanels.Thetransfectedtachyzoiteswerealsosubjected
tostresstherebyconvertingtobradyzoites(seeMaterialsandMethods).(C)ActivitiesoftheENO1andENO2promotersduringtachyzoitetobradyzoiteconversion.
The plasmids E2F or E1F contain the 30-UTR of SAG1 gene while E2F10 and E1F9 contain the 30-UTR of ENO2 and ENO1, respectively. The CAT-constructs
depicted on the left-handside (E2F versus E2F10 and E1F versus E1F9) were transfected into tachyzoites and these organismswere dividedequally into two flasks
of human foreskin fibroblasts. After 6 h of invasion, one flask was subjected to experimental stress conditions to induce bradyzoite conversion and the second flask
was kept in tachyzoite growth conditions (see Materials and Methods). Levels of CAT signal in tachyzoites and bradyzoites were determined after removing
thepromoterlessCATvectoractivitiesandadjustmentsforb-galactosidaseactivityusedasinternalcontrol.Thedataareaveragesoffourindependentexperiments.
Error bars represent the mean and SD values of four independent experiments.
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that downregulate the expression of the bradyzoite-speciﬁc
ENO1 in the tachyzoite stage (Figure 2B). As judged from
the CAT reporter gene activity, deletion of this region
(constructs E1F1 to E1F5) showed a steady-level increase
in promoter activity in the tachyzoite. The deletion of this
620 bp region in E1F5 construct resulted in 20-fold increase
of CAT activity (Figure 2B). Further deletions of ENO1 pro-
moter to give constructs E1F6 to E1F8 produced a further
reduction in CAT activity until the background.
When these series of ENO2 constructs (E2F–E2F5) were
transfected in tachyzoites which were then subjected to stress
conditions inducing bradyzoites (see Materials and Methods),
the ENO2 promoter analysis revealed two upstream repression
sites (nucleotides  1929 to  1067 and  456 to  222) which
were not previously detected in tachyzoites (Figure 2A), sug-
gesting that the transcriptional activity of ENO2 promoter in
bradyzoites relies on different components. In contrast, the
promoter activity of the largest construct E1F which contains
negative regulatory elements (nucleotides  1245 and  625)
as evidenced in tachyzoites, increased  30-fold following
bradyzoite differentiation (Figure 2B). The other smaller con-
structs tested (from E1F1 to E1F8) in bradyzoites gave a
progressive decrease of CAT activity down to the basal pro-
moter activity reached in E1F8. In order to test the effect of the
ﬁrst exon and the intron on CAT activity, other CAT-chimeric
constructs containing either the ﬁrst exon or both exon and
intron (see the map shown in Figure 1A) were generated from
ENO1 and ENO2 promoters with their respective exon and
intron sequences. Transfection of these constructs did not
appear to produce any signiﬁcant changes in CAT activity
when compared with that of the ENO1 and ENO2 promoter
alone. This suggested that the ﬁrst exon and the intron prob-
ably did not contain any sequences regulating the transcription
of the ENO1 and ENO2 genes.
The ENO1 and ENO2 upstream regions contain
differentially regulated promoters
When the 30-UTR of SAG1 was replaced by the ENO2 or
ENO1 30-UTRs to generate respectively the E2F10 and
E1F9 constructs, a signiﬁcant increase of CAT activity was
observed as compared to E2F and E1F (Figure 2C). The
repression of the ENO1 promoter activity seen in the distal
DNA element (fragment nucleotides from  1245 to  625)
was still present and, this region appears to have no inﬂuence
on the ENO2 promoter activity when it is placed downstream
of the CAT gene in the E2F10 construct (Figure 2C). The
generation of these two constructs allowed us to investigate
the transcriptional regulation occurring at both downstream
and upstream regions of ENO1 and ENO2 during tachyzoite
to bradyzoite conversion. To do this, we compared the CAT
activity of promoter constructs with or without their respective
30-UTRs during tachyzoite to bradyzoite conversion. The
expression of each CAT construct was affected differently
by incubation of transfected tachyzoites in low CO2 growth
conditions that induce conversion to the bradyzoite stage (19).
While CAT expression from E2F and E2F10 was reduced to
2- to 6-fold in induced bradyzoites, that of E1F and E1F9
was induced to 10- to 25-fold (Figure 2C). On the other hand,
the expression of the CAT-chimeric constructs driven by the
promoter and/or the 30-UTR of the tachyzoite-speciﬁc ENO2
gene was reduced 2- to 6-fold (50–85% reduction compared to
CAT expression in tachyzoite) when the tachyzoites convert to
bradyzoites while the constructs from the bradyzoite-speciﬁc
ENO1 gene were upregulated to 10- to 25-fold in the induced
bradyzoite. The reduction or increase of CAT expression
are consistently higher in E2F10 and E1F9 than E2F and
E1F, conﬁrming that these CAT-chimeric constructs with the
respective 30-UTR of ENO1 and ENO2 gave more pronounced
CAT activity than constructs with the heterologous SAG1
30-UTR.
Evidence for specific protein–DNA interactions
within the promoter of ENO1
To characterize the cis-regulatory elements and trans-acting
factors that play a role in the transcriptional regulation of the
ENO1 gene in tachyzoites, we performed a series of EMSAs.
DNA fragments from the intergenic region between the ATG
initiation codon ofthe ENO1 gene and the polyadenylationsite
ofENO2weregenerated byPCRandtestedforproteinbinding
in EMSA. We tested protein binding with a nuclear lysate
made from puriﬁed tachyzoites. Out of the ﬁve PCR fragments
from the promoter of ENO1, only two fragments located at
the distal regulatory region of ENO1 promoter bound proteins
in the tachyzoite lysate. The fragments, referred to as E1/4
and E1/5 were 323 and 579 bp, respectively (Figure 3A). The
larger DNA fragment bound several proteins strongly while
the smaller fragment bound weakly to one protein (Figure 3B,
lanes 2). The binding of proteins to fragment E1/4 and
E1/5 was speciﬁc since competition with 10- to 50-fold excess
of the same unlabelled fragment prevented binding to the
labelled fragment (Figure 3B, lanes 3 and 4). Competition
with similar concentrations (10- to 50-fold excess) of unla-
belled non-speciﬁc fragment E1/2 had no effect on protein
binding (Figure 3B, lanes 5 and 6, arrowheads). The speciﬁc
regions that bind proteins in the 579 bp fragment were then
determined with smaller overlapping PCR fragments. The
fragment was divided into two overlapping fragments of
424 and 161 bp, respectively. The 424 bp fragment was further
divided into seven fragments of decreasing sizes of 349, 296,
234, 76, 75, 63 and 49 bp, respectively. On the other hand, the
161 bp fragment was divided into two overlapping fragments
of 90 and 93 bp, respectively. Two smaller overlapping frag-
ments of 57 and 52 bp were obtained from the 93 bp fragment.
All the fragments were labelled and tested for protein binding
by EMSA. From these, only four fragments referred to as
fragments 5b (63 bp), 7b (57 bp), 7c (52 bp) and 9 (49 bp)
bound proteins in EMSA (Figure 3C). Double-stranded oligo-
nucleotides were then designed with the information obtained
from the EMSA studies and tested for protein binding. These
oligonucleotides also bound proteins in EMSA with the same
gel shift patterns, conﬁrming the data obtained with the PCR
fragments. Competition with speciﬁc oligonucleotides demon-
strated that the oligonucleotides were binding proteins spe-
ciﬁcally. The sequences in the oligonucleotides were checked
for homology to transcription factor binding elements in the
TRANSFAC and TFSEARCH databases (28). The putative
cis-regulatory elements identiﬁed in the distal regulatory ele-
ments of ENO1 promoter and the consensus sequences for
these elements are summarized in Figure 8C.
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present in the ENO1 promoter abolish protein
binding in EMSA
Oligonucleotide 5b1 (45 bp) was generated from part of the
63 bp PCR fragment 5b that gave the most intense signal in
EMSA. This strong signal corresponds to a complex of pro-
teins with at least one intensely binding protein and at least
two minor ones (Figure 3C, left panel). One of the protein
binding cis-regulatory sequences in oligonucleotide 5b1 was
found to be similar to the yeast stress response element
(STRE) (29–31). The putative STRE element located within
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onlytwofragmentsE1/4andE1/5bindingspecificallytoproteinsinEMSAwithtachyzoitenuclearextractsareindicated.Thenumbers9,5b,7band7crepresentthe
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mutated to TTTAAAAAT, while the rest of the sequence
remained the same as in oligonucleotide 5b1 (Figure 4A).
The mutated oligonucleotide was then tested for protein bind-
ing in EMSA and in competition experiments. It was evident
(Figure 4B, panel Mut5b1, lanes 6 and 7) that the mutated
oligonucleotide no longer bound any protein in the nuclear
lysate and neither was it capable of competing for binding
of the nuclear lysate to the normal oligonucleotide 5b1
(Figure 4B, panel 5b1, lane 4). To determine whether only
STRE-like factors are binding to oligonucleotide 5b1, the
canonical STRE from Saccharomyces cerevisiae (see nucleo-
tide sequence in Figure 4A) was tested in competition experi-
ments. We noticed that the yeast STRE was unable to
efﬁciently disrupt the binding of the labelled 5b1 to the T.gon-
dii nuclear extract (Figure 4B, lane 11). Because the canonical
yeast STRE and the T.gondii oligonucleotide 5b1 share only
the AGGGG motif of STRE, these data suggested that other
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Figure 4. Competitive band shift analysis with normal and mutated oligonucleotide 5b1. (A) The oligonucleotide 5b1, the mutated oligonucleotide 5b1 (mutated
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1730 Nucleic Acids Research, 2005, Vol. 33, No. 5factors also bind to the oligonucleotide 5b1 in addition to
STRE. This conclusion was strongly supported by the
ability of oligonucleotide 5b1 to completely disrupt binding
of T.gondii nuclear extract to the yeast canonical STRE
(Figure 4B, lane 15). In addition, these results demonstrate
that a STRE-like factor that is capable of speciﬁcally binding
to yeast STRE is present in T.gondii nuclear lysate (Figure 4B,
lane 13). Taken together, these data indicate that the STRE
may play a central role in assembling the transcription com-
plex that binds to oligonucleotide 5b1. It is possible that a
complex of two or more proteins is formed by protein–DNA
and protein–protein interaction.
Specific proteins binding to the promoter of ENO2
From the 50 promoter region of ENO2, four fragments were
generated by PCR and an additional four were generated by
using restriction enzymes EcoRI, BamHI, PstI and HindIII
(Figure 5A). Two other PCR fragments were generated from
the ENO2 intron. Fragment E2/1 was 191 bp and included
Probe
Competitor
Extract
123
-+ +
- -
3b
3a
123
- ++
--
3a
123
-++
- - 100
- - 3c
3c
123
-++
2a
- - 150
-- 2a
1
-
-
-
2b
23
++
- 150
- 2b
Fold excess
A
C
ENO2
ATG
H R B P
A
E2/1
E2/3
E2/2
3c
2a
B
3b
2b
3a
CGCGGAC GCGGATCC GCACACGTACAAGCGGGCACTTCGTTTCCGTCTGTTTCGC
AATGGGCTACAATGTAAGTATCCAAAGAGCACCCCATCATCCGATACCGGACGC
GGTGCAACCCATCTCCCAAGAAACGACGTGAACGCTGATAGCACGAGCTACGGT
GCACGTCACGCGGCTGCCTCTGCCGACTCTCGGCACCCGGTTACGTGTTAGTAGA
TCTCTGGAAACGCCCCCTGGACGCGGAACGGCGGTCGCATGTCTCATTTGAAAAA
TAGGGTGCTACGCCAGGGGTGGTCCTCGCTCAAGTGCC
Unbound
probe
3b
- - 100 100 - -
Figure 5. TheproximalregulatoryelementsofENO2promoterisatargetforDNA-bindingproteins.(A)Aschematicrepresentationshowingthe50-flankingregion
ofENO2thatwasusedtogenerateDNAfragmentsforproteinsbindinginEMSA.ThetwofragmentsE2/2andE2/3bindingspecificallytoproteinsinEMSAusing
the tachyzoite nuclear extracts are indicated. (B) The nucleotide sequence of the contiguous E2/2 and E2/3 fragments is depicted with the oligonucleotides further
designed for protein binding in EMSA. (C) Band shift assay with oligonucleotides from E2/2 and E2/3. Oligonucleotides 3a, 3b and 3c: lane 1, free probe; lane 2,
no competitor; lane 3, specific competitor (50-fold or 100-fold excess); and oligonucleotides 2a and 2b: lane 1, free probe; lane 2, no competitor; lane 3, specific
competitor (150-fold excess). The arrowheads show the DNA–protein complexes.
Nucleic Acids Research, 2005, Vol. 33, No. 5 1731sequences of the ﬁrst exon. Fragment E2/2 was 140 bp and
extended up to  291 bases upstream of the ATG codon. Frag-
mentE2/3was162basesandextendedafewbasesupstreamof
the BamHI site (Figure 5A). When thesefragments were tested
for protein binding in EMSA, only fragments E2/2 and E2/3
were found to speciﬁcally bind several proteins (data not
shown). The nucleotide sequence of fragments E2/2 and E2/
3 is shown in Figure 5B. To better deﬁne the interaction of the
several proteins that bind to fragment E2/2 and E2/3, we have
generatedﬁvePCRfragmentsfromthisregion.Twofragments
2a and 2b of 82 and 74 bp were generated from fragment E2/2
(Figure5B).Ontheotherhand,fragmentE2/3wasdividedinto
threesmalleroverlappingfragmentsreferredtoasfragments3a,
3b and 3c whose sizes ranged from  40 to 50 bp (Figure 5B).
Gel shift assays using the labelled fragments showed that the
fragmentsboundaparticularsetofproteins(Figure5C,lanes2).
Using the information from EMSA analysis, double-stranded
oligonucleotides were designed and these were tested for pro-
tein binding in EMSA. In all, three double-stranded oligonuc-
leotides referred to as oligo 2p1, oligo 2p2 and oligo 3b were
synthesized from the promoter of ENO2. The sizes of the oli-
gonucleotides were 36, 42 and 35 bp, respectively. When these
were tested on EMSA, it was apparent that some of the oligo-
nucleotides bound more than one protein (Figure 6B, lanes 2).
Oligonucleotide 2p1 bound two proteins whereas oligonuc-
leotide 2p2 bound three major proteins and few minor ones
revealed upon longer exposures (Figure 6B, left panel). The
speciﬁcity of the oligonucleotides binding to the proteins was
tested in assays where the corresponding unlabelled oligonuc-
leotides were included in the binding reaction before the addi-
tionofthelysates.AscanbeseenfromFigure6B(lanes3),100·
molar excess of the unlabelled oligonucleotides was able to
disrupt the speciﬁc binding. Competition experiments with
two overlapping oligonucleotides of 3b1 and 3b2 (Figure 6A,
upper sequence) showed that these two oligonucleotides
3b1 and 3b2 could not compete efﬁciently for protein binding
with the labelled 3b oligonucleotide (Figure 6B, lanes 4 and 5
comparetolane3).Incontrast,itwasfoundthatoligonucleotide
2p2b and 2p2c could each compete for a single protein binding
to oligonucleotide 2p2, the 42 bp oligonucleotide that bound
to three or more different proteins (Figure 6B, right panel,
lane 2 compared with lanes 5 and 6). To identify DNA
regulatory elements that probably bind transcription factors,
the oligonucleotide sequences were checked for homology
to sequences in the TRANSFAC and TFSEARCH databases
(Figure 8C).
The ENO1 promoter activity and STRE binding are
increased under stress-induced
bradyzoite differentiation
In order to test the DNA–protein interactions under the stress
conditions tested above, nuclear extracts were prepared from
stress-induced bradyzoites (CO2 starvation method) and used
for EMSAs. The speciﬁc DNA-binding activities in EMSAs
described above have been obtained by comparing equal
amount of nuclear extracts from non-stressed tachyzoites
and stress-induced bradyzoites (Figure 7). In comparison to
the tachyzoite EMSAs signals (Figure 7, lanes 2), these spe-
ciﬁc DNA-binding activities were signiﬁcantly increased
when the STREs (oligonucleotides 5b1 and 5b2 of ENO1
promoter) were incubated with nuclear extract from stress-
induced bradyzoites (Figure 7, lanes 5 compare to lanes 2).
In contrast, no marked difference was seen when the nuclear
extract from stress-induced bradyzoites were used for DNA-
binding activities with the oligonucleotides 7b+7c and 9 (data
not shown) containing the putative heat shock elements
(HSEs) of T.gondii. Importantly, neither the HSE-
containing oligonucleotide 7b+7c (lane 8 compare to lane 2)
nor the oligonucleotides 5b1 and 5b2 (data not shown) dis-
played an increased DNA-binding activities using nuclear
extract from tachyzoites subjected to heat shock treatment.
This suggests that the HSE-like motifs in the ENO1 promoter
may not be functional as heat shock-inducible elements under
our experimental conditions.
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Figure 6. Localization of protein binding within the 35 and 42 bp DNA of
oligonucleotides 3b and 2p2. (A) The sequence of oligonucleotide 3b and the
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self oligonucleotides shownin (A). Note the disappearance of the oligonucleo-
tide protein complexes in lanes 5 and 6 (arrowed).
1732 Nucleic Acids Research, 2005, Vol. 33, No. 5DISCUSSION
To understand stage-speciﬁc gene transcription in the proto-
zoan parasite T.gondii, it is necessary to identify regulatory
DNA elements and the proteins binding to these elements.
The available information on the DNA elements that bind to
transcription factors in the T.gondii genome is sketchy. Only
few elements have so far been characterized and shown to be
critical for transcription of T.gondii genes (22–24). The cur-
rent study was performed to identify the regulatory regions of
T.gondii enolase genes that bind putative transcription factors.
We summarize in Figure 8A–C, the deletion constructs for
promoter activity, the transcriptional cis-regulatory elements
and the putative trans-acting factors identiﬁed in the ENO1
and ENO2 genes. This is the ﬁrst detailed demonstration by
gel shift assay and mutagenesis of cis-regulatory elements in
T.gondii promoters that bind to putative regulatory factors.
The biochemical isolation and further characterization of
these transcription factors are underway.
T.gondii enolase is a differentially expressed glycolytic
enzyme (12,13). The two distinct enolases (ENO1 and ENO2)
areeachexpressedatonlyonestageinvivo.ENO1isexpressed
onlyinthebradyzoitestageandENO2onlyintachyzoites(13).
Like T.gondii enolase, differential expression of other enolase
genes is linked to stress factors, disease state or developmental
transition. In mammals, enolase is a dimeric enzyme which
exhibit cell type speciﬁc isoforms and is differentially
expressed in degenerating and regenerating skeletal muscle
myoﬁbres (32,33). S.cerevisiae like T.gondii, has two enolase
genes designated ENO1 and ENO2 which are differentially
expressed. ENO2 is induced more than 20-fold in cells grown
on glucose while ENO1 is not (34,35). The expression of
ENO1 was found to be similar in cells grown on glucose
and in cells grown on gluconeogenic carbon sources (35).
The ENO2 promoter was found to contain a cis-acting regu-
latory region mediating glucose-dependent induction of gene
expression (34). Taken together, these studies show that stress
induces transcription of enolase genes in S.cerevisiae, and
T.gondii enolases may also be regulated by a similar mechan-
ism. Differential gene expression in protozoan parasites prob-
ably serves as a strategy for these organisms to adapt to
different environmental conditions. Environmental, oxidative,
heat and nutrient limitation stresses are some of the stressful
conditions that protozoanparasites encounter within or outside
theirhosts.Therefore,theseparasiteshavetokeeponchanging
the expression patterns of their genes in order to adapt to their
current environment. The STRE-binding activity detected in
nuclear extract from stress-induced bradyzoites was signiﬁc-
antlyhigherthanthatfromnon-stressedtachyzoites.Becauseit
has been documented that tachyzoite to bradyzoite conver-
sion are induced by different stress conditions (8–10,36), it
is tempting to speculate that the presence of stress responsive
elements in the promoters of the T.gondii enolase genes may
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complexes with ENO1 promoter DNA oligonucleotides containing STRE motifs (5b1 and 5b2) or HSE-like motifs (7b+7c) and nuclear extract from non-stressed
tachyzoites(lanes 1–3), nuclear extract from stress-induced bradyzoites (lanes 4–6) or nuclear extract from heat shock treated tachyzoites (oligo7 b +7c, lanes 7–9).
Equal amount of nuclear extracts have been used. Lane 1, free probe; lane 2, probe with tachyzoite nuclear extract and no competitor; lane 3, probe with tachyzoite
nuclear extract and specific competitor (200-fold excess of the homologous cold fragment); lane 4, free probe; lane 5, probe with stress-induced bradyzoite nuclear
extractandspecificcompetitor(200-foldexcess);lane6,probewithstress-inducedbradyzoitenuclearextractandspecificcompetitor(200-foldexcess);lane7,free
probe; lane 8, probe with nuclear extract from tachyzoite heat shock treated and no competitor; and lane 9, probe with tachyzoite nuclear extract and specific
competitor (200-fold excess). Arrowheads show the DNA–protein complexes.
Nucleic Acids Research, 2005, Vol. 33, No. 5 1733be indicative of the responsiveness of these genes to a variety
of stress conditions. Similarly, in S.cerevisiae, the multistress
responseelementmediatesinductionoftranscriptionbyavari-
ety of stresses including oxidative stress, nitrogen starvation,
glucose starvation and approach-to-stationary phase (29–31).
The zinc ﬁnger transcription factors Msn2p and Msn4p are
required for transcription induction through the STRE and dis-
ruption of the two genes results in sensitivity to a variety of
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Figure8.(AandB)OverviewoftheresultsobtainedbypromoteranalysisandbyEMSAs.ThepromoterregionsofENO1andENO2areshown.Theforwardprimers
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cis-regulatory elements and the corresponding putative trans-acting or transcription factors are indicated in the table. The oligonucleotide sequences were checked
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1734 Nucleic Acids Research, 2005, Vol. 33, No. 5stresses (29). It is interesting to note that the T.gondii HSE
without the canonical motif, such as yeast HSE, is also
found in the T.gondii enolase promoters. In yeast, the single
essential HSF binds constitutively to DNA and allows a wide
range of distinct interactions of DNA binding domains within
HSEs. Therefore, yeast cells utilize this single HSF to activate
the expression of a wide variety of genes in response to heat
and other stress, and to also coordinate the expression of genes
required for growth under normal physiological conditions
(37). Although the presence of STRE and HSE elements in
the promoter does not imply functionality of these elements
in vivo, it is interesting to note that both STRE and HSE
elements have also been recently identiﬁed in T.gondii Hsp
70 genes (38). Examination of the Toxoplasma genome data-
base(http://toxodb.org)doesnotrevealanyobviouscandidates
homologoustoknownHSFsorSTRE,suggestingthatT.gondii
transcriptionalfactorsbindingtothesecis-regualtorysitesmay
either be unrelated or distantly related to the classical HSF and
STRE of yeast or higher eukaryotes. Interestingly, the genera-
tionofprogressivedeletionsinthe 1245to 804bpregionof
ENO1 that removed the HSE and STRE motifs led to a signi-
ﬁcant increase of ENO1 promoter activity in the tachyzoites
whereas the presence of these cis-acting elements gave no
obvious inﬂuence on promoter activity in the bradyzoites
(Figure 2). This suggests that the region between  1245 and
 804 bp contains cis-acting elements that are bound by
negativeregulatorsinthetachyzoitesbutnotinthebradyzoites.
In addition, further increase in ENO1 promoter activity was
observed in a construct lacking an additional DNA fragment
of 179 bp, suggesting that the whole 620 bp region seems to
participate in the stage-speciﬁc expression control. This also
suggests that in addition to both STRE and HSE, other
sequences may be involved in the stage expression control
of promoter activity, indicating that there is an additional
layer of complexity due tothe involvement of othersequences.
Recent studies show that enolase has a multifunctional
role depending on its subcellular localization. In Arabidopsis
thaliana, enolase is required for cold acclimation and chilling
resistance and its mutation impairs cold responsive gene
transcription (39). In animal cells, an alternative transcription
product of enolase referred to as MBP1 is a DNA binding
transcription factor (40). MBP1 represses the expression of
c-Myc proto-oncogene by binding to the TATA box, and thus
preventing the TATA-binding protein’s binding to the pro-
moter (40). Interestingly, our recent localization of T.gondii
enolases in the parasite nucleus suggests other possible func-
tion for this protein (41).
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